Charles P. Cooley - Senior Vice President, Treasurer and Chief Financial Officer
Analyst
Thank you, James, and good morning everyone. I'll start my comments on the quarter with a few headlines and then will get into a more detailed discussion. Earnings this quarter reflected record performance in the Lubrizol Additives segment for volume and operating income. The segment delivered double-digit volume and revenue growth in all international zones. The Lubrizol Advanced Materials product lines produced mixed results and experienced generally weak demand in North America. As James just discussed, business improvement initiatives for the Performance Coatings product line were announced and will result in restructuring and impairment charges in the first and second quarters. Both segments took additional price actions in the quarter to address higher raw material and operating costs. The net result for the quarter was strong overall operating performance, as we carried our 2007 momentum into 2008. If you're following along with the PowerPoint presentation on our website's Investor Earnings Release page, I'm now on page 4 where you can see the consolidated earnings for the first quarter of 2008 compared with the year-ago period. As a reminder, all references to earnings per share will be on a diluted basis. This morning we announced that consolidated earnings for the first quarter of 2008 were $73.6 million, or $1.06 per share, including restructuring and impairment charges of $0.04 per share primarily related to the disposition of a North American coatings production facility. Consolidated earnings for the first quarter of 2007 were $71.3 million, or $1.02 per share, and included a restructuring credit of $0.03 per share related to the gain on sale of the Bromborough, U.K. site. When we exclude the restructuring and impairment charges and credits in both years, adjusted earnings of $1.10 per share for the quarter were 11% higher than the first quarter of 2007. The primary drivers of consolidated earnings growth were an improvement in the combination of price and product mix, higher volume, favorable currency, a lower effective tax rate, reduced net interest expense and contributions from acquisitions. These positive factors to earnings more than offset the impacts of higher raw material and manufacturing costs, and higher selling, testing, administrative and research, or STAR, expenses. In addition, other income in 2007 benefited from the gain on sale of real estate of approximately $5 million and there was no significant similar benefit in 2008. Slide 5 compares the adjusted earnings for the first quarters of 2008 and 2007. We have noted some of the non-operating and economic factors that influenced our results for the quarter. First, as just noted, we booked a gain on the sale of real estate in the first quarter of 2007, whereas in the first quarter of 2008 there was no similar benefit. Second, currency favorably impacted the quarter by an estimated $1.13 per share based on our pro-forma calculation that compares actual results to pro-forma results when translated at the prior-period's exchange rates. Finally, a lower effective tax rate on earnings, as adjusted, contributed approximately $.05 per share when compared with the relatively high effective tax rate in the first quarter of 2007. Turning to slide 6, consolidated revenues increased 14% from the first quarter of 2007 to $1.23 billion. Compared with the year-ago period, volume increased 6%, improvements in the combination of price and product mix increased revenues by 4%, and currency also was 4% favorable to revenues. Included in these factors was the incremental impact from our 2007 acquisitions, which contributed 3% to consolidated revenues in the quarter. Gross profit rose 5% in the quarter as the higher revenues more than offset higher raw material and manufacturing costs. Gross profit margin percentage declined 200 basis points from the year-ago quarter, but was up 20 basis points sequentially. Continuing the pattern we've seen over the last several years, the gross profit percentage declined year-over-year, even though gross profit dollars increased, because the rate of increase in revenues due to pricing has outpaced the rate of increase in gross profit dollars. STAR expenses increased 6% from the first quarter of 2007. Research and testing expenses of $54 million in the quarter were up 5% largely due to higher costs for salaries and benefits as well as unfavorable currency. Selling and administrative expenses of $109 million were up 6% with approximately one-half of the increase due to unfavorable currency. The balance of the increase related to project costs associated with our SAP implementation in the Advanced Materials segment. Higher costs for salaries and benefits, reflecting increases of both compensation expenses and growth resources in Advanced Materials, were offset by reduced incentive compensation expense. Adjusted EBIT, which excludes restructuring and impairment charges and credits, rose 1% in the quarter to $125.6 million. Net interest expense was 20% lower than the year-ago quarter as lower interest expense more than offset lower interest income. Turning to taxes, earnings as adjusted for restructuring and impairment charges and credits were taxed at an effective rate of 31.6% in the quarter, as compared with 35.0% in last year's first quarter. This lower rate was driven mainly by lower U.S. tax costs associated with foreign subsidiary earnings. I'll note here that for the remaining three quarters of the year we forecast the effective tax rate to be higher than the prior year mainly because we do not expect a repeat of favorable discrete tax items we had in 2007. And now I'll turn to segment results, which are shown starting on slide 7. Revenues for the Lubrizol Additives segment in the quarter were up 19% year-over-year on 10% higher volume. The combination of price and product mix improved revenues 5% and currency contributed 4%. Volume set a quarterly record and was particularly strong outside of North America. Latin America volume increased 34%; Europe was up 13%; Asia-Pacific was up 12%, and North America volume rose 1%. The quarter benefited from a favorable comparison with the first quarter of 2007 as well as from changes in customer order pattern in this year's first quarter. In addition, the two acquisitions completed in 2007 constituted about 25% of the volume growth in the quarter. Excluding these factors, our quarterly volume grew approximately 6% primarily due to business gains in Latin America that were realized in the second quarter of 2007, as well as to growth in the Asia-Pacific region, particularly in China. We attribute these business gains to the strength of our new products and technologies, which have contributed to our customers' success. The global price increase that Lubrizol Additives announced late in the fourth quarter of 2007 was implemented fully during the first quarter of 2008. We also announced a global increase in February, which is being implemented during the second quarter. Since the time of the February price increase, raw material and operating costs have continued to rise. As James commented, we have entered a period where we may be chasing material cost increases with further pricing actions, so we are monitoring the situation carefully. But I want to note that we maintained our unit material margins in the quarter compared to the first quarter of 2007. Segment operating income in the quarter increased 12% primarily as a result of higher volume, favorable currency and the contributions from last year's acquisitions. As I referenced earlier, in last year's first quarter Lubrizol Additives earnings included a gain on sale of real estate. Excluding from both periods the contribution from acquisitions and the gain on sale, operating income increased 15%. Turning to the Lubrizol Advanced Materials segment on slide 8, first quarter revenues were up 5% over last year. The increase reflected a 4% favorable impact from the combination of price and product mix, a 3% favorable currency impact and a 2% decline in volume. This is the largest increase in the combination of price and product mix that we have seen in this segment since the beginning of 2006. In fact, our unit material margins in this segment were higher in the quarter versus last year's first quarter. More than one-third of the volume decline recorded by the segment in the quarter was attributed to the loss of some AMPS specialty monomers business, mainly in Europe, as the result of production problems last year. Excluding this business loss, European volumes declined 3% due to softness in the textiles market. Asia-Pacific volumes grew 11% thanks to double-digit growth in Performance Coatings and TempRite Engineered Polymers. North American volumes were down 3%, primarily due to the impact of the very weak housing and textile markets. I'll now go into the Advanced Materials product lines in a little more detail. The Noveon Consumer Specialties product line had revenues of $109 million, up 6% from the first quarter of 2007. Volume grew 9%. A significant portion of the volume growth was in North America where our lower margin surfactants business showed strong growth, and our new liquid Carbopol products continued their excellent performance with 33% higher volume. We did see a decline in our powdered Carbopol products primarily driven by customer order pattern. In fact, we are seeing a rebound as April orders were very strong. Revenues in the Performance Coatings product line were $134 million in the quarter, which was level with the first quarter of 2007. This product line continues to be impacted by the weakness in the North American textiles and coatings industries that we have discussed in previous teleconferences. We also experienced weak demand in Europe particularly in our textiles business. All coatings product areas showed volume declines except our hyper dispersants business, which performed well in all regions. I'd like to elaborate on James' comments regarding our plan to improve the performance of our Coatings business. The Coatings team has commenced a series of business improvement actions. The actions announced to date resulted in restructuring and impairment charges of $0.04 per share in the first quarter, and will generate at least another $0.04 of charges in the second quarter. These actions are expected to generate cost savings of $3.5 million to $4 million in 2008, and over $6 million in 2009. We hope to take further steps this year that would produce additional benefits. The Engineered Polymers product line, consisting of TempRite and Estane engineered polymers, reported revenues of $158 million in the quarter, up 10% from the first quarter of 2007. Estane products had a record quarter for revenue, volume and earnings as we experienced double-digit revenue growth in all regions. We had continued strength in North American film and sheet applications due to strong orders with our major customers, and significant growth in a new electronic industry application. We also have been successful with several pricing actions over the last six months. Global volume for TempRite CPVC products increased 4% in the first quarter compared with the year-ago period. All international regions saw double-digit increases thanks to strong customer demand. North American volume was down 4% as a decline in residential plumbing volumes more than offset a 15% increase in our commercial plumbing and fire sprinkler applications. TempRite had the largest year-over-year decline in profit contribution of all of the Advanced Materials businesses, and this decline was almost entirely due to material cost pressures. In April we announced significant price increases in all regions to offset the steep run up in raw material costs, and we expect to see the full impact of the price increases in the third quarter. To summarize the results of Lubrizol Advanced Materials, segment operating income in the quarter decreased 32% from the first quarter of 2007. Our Estane business delivered great performance and is well-positioned for a very good year. Noveon Consumer Specialties results for the quarter were less than expected due to changes in order pattern; however, we believe the business will meet our earnings expectations for the year. Earnings in our TempRite business were significantly below last year's results as the business was impacted by the very weak North American housing market and higher raw material costs. And to address the higher material costs, we announced price increases in the quarter that we forecast will boost significantly the product line's second half results. First quarter results in our Performance Coatings product line also were behind last year largely due to weak North American demand, especially in textiles, and we have several initiatives underway to improve the operating margins of this business. Incremental expenses associated with the SAP implementation also impacted the segment's quarterly results. I'll now comment on several other financial items noted on slide 9. Corporate expenses were $21 million in the first quarter of 2008 and were comparable with the first quarter of last year. We generated $43 million in cash flow from operations in the first quarter, down from $98 million in the same period in 2007, largely the result of our efforts to increase inventories in Lubrizol Additives. By contrast, during the first quarter of 2007 we were reducing inventories. Also contributing to the working capital build in the quarter were the company's strong revenues and higher inventory costs. All that said, we continued to manage our working capital well in the quarter. Collection efficiency and inventory days improved compared with the first quarter of 2007. Regarding our uses of cash in the quarter, capital expenditures were $52 million. We repurchased 430,000 common shares for $25 million. And we paid out dividends of slightly over $20 million, reflecting the 15% increase announced last April. This past Monday our Board of Directors approved a 3% dividend increase effective this quarter. As the result of these activities, our cash balance at the end of the first quarter of 2008 was $459 million, compared with $502 million at December 31st, 2007. We currently anticipate using some of this cash in December to retire $200 million in notes. For the 12 months ending March 31, 2008, return on invested capital was 11%, compared with 10% for the comparable period in 2007. Now I'll turn to our outlook on slides 10 and 11. Our economic assumptions behind our updated 2008 outlook are unchanged from those we expressed at the February 8 teleconference. That is, we expect the continuation of essentially the same fundamentals we saw in 2007 in the broad array of end-use markets that we serve. In view of our strong first quarter results and our projections for the balance of the year we are increasing our guidance. Our new guidance is $4.17 to $4.37 per share, including $0.08 per share for restructuring and impairment charges related to the improvement initiatives in our Performance Coatings product line that I described earlier. Our revised guidance for adjusted earnings, excluding restructuring and impairment charges, is in the range of $4.25 to $4.45 per share, which is a 5% to 10% increase in adjusted earnings compared with 2007 results. Here are the updates to our key assumption, consolidated revenue growth of approximately 11% to 12%, and consolidated adjusted EBIT growth of 11% compared with 2007. For Lubrizol Additives, excluding acquisitions, we continue to forecast volume growth consistent with the 0% to 1% long-term growth rate of the additive industry. For Lubrizol Advanced Materials, we now project volume to be unchanged from 2007 due to North American demand weakness. We are modeling raw material costs to increase through mid-year and then stabilize in the second half. We are modeling STAR expenses to be approximately 13.5% of revenues. We are modeling net interest expense to be approximately $65 million. We have revised downward our effective tax rate assumption for the year to 32.0% and we are modeling the euro to average $1.55 for the remainder of the year. As we noted at the February teleconference, we expect a tough comparison in the first half but a quite favorable comparison in the second half. A significant factor behind this pattern is the unusually low effective tax rate in the second quarter of 2007, which was driven by some favorable discrete items. We are amending our expected earnings split to be more balanced between the first half and second half of the year when compared with our previous guidance of a 51:49 split. I'll note a few factors that would enable us to hit the upper end of our range including better margin recovery due to pricing actions, higher volume growth, especially in Consumer Specialties and Engineered Polymers, lower operating expenses, and a lower effective tax rate. The key updates to our cash flow outlook are shown on slide 12, and are these; capital spending is projected to be between 225 and 235 million dollars. We are increasing our capital spending estimate as a result of the Additives manufacturing expansion plan that we announced in March. This higher level of spending compared with 2007 is driven by production capacity expansion in both segments and by the SAP implementation. And we are now assuming a working capital build of approximately $100 million, mostly in lubricant additives inventory, due to higher material costs as well as our plans to maintain security of supply for our customers. Though not a change, I do want to point out that we currently are targeting to repurchase approximately $100 million of our shares in 2008, and, as I mentioned earlier, our Board raised the quarterly dividend to $0.31per share effective in the second quarter. So, I would like to conclude by saying that we're obviously very pleased with our first quarter performance in 2008. Our overall fundamentals remain strong, and we feel we're well-positioned for the balance of the year. The second quarter is off to a good start with April sales the highest of the year, reflecting healthy demand in both segments. Now, with that, we can open it up for Q&A. Terry. Question And Answer